Sinovac snags vaccine order

The Beijing Centers for Disease Control and Prevention selects Sinovac Biotech Ltd. (SVA +1%) as one of four suppliers of influenza vaccines to the citizens of Beijing for 2014. Each manufacturer will supply a minimum of 300,000 doses, but could be greater depending on demand. Last year, the company supplied ~400K doses of its Anflu vaccine.

From other sites
Comments (3)
  • clack
    , contributor
    Comments (71) | Send Message
    If SVA can start delivering some earnings for all their hard work they will soon be a $10-12 stock. They are doing great work but the earnings lag for now. I'm hoping we get some good earnings news soon.
    23 Jul 2014, 12:46 PM Reply Like
  • GrowthGeek
    , contributor
    Comments (3203) | Send Message
    Earnings will definitely come for SVA clack. Excellent company at a bargain basement price. HFM disease vaccine will be huge for SVA in the near future as well--then earning will really rocket.
    25 Jul 2014, 04:04 PM Reply Like
  • clack
    , contributor
    Comments (71) | Send Message
    I first purchased SVA in June 2005. I've been patient and seen boom and near bust. Was out of it for a time. The last few years have been very promising.
    25 Jul 2014, 08:14 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs